Innovative Midfoot

Coming – December 1

The Next Frontier in Orthopedic Innovation

Date and Time

December 1

–

4:00 PM ET / 1:00 PM PT

Details will be shared with confirmed attendees

About this Event

A Billion-Dollar Opportunity Hiding in Plain Sight

Millions of Americans suffer from painful, debilitating conditions affecting the middle of the foot, yet this important segment of orthopedic surgery has seen relatively little innovation. Traditional procedures can be complex, time-consuming, and unpredictable, creating a significant unmet need for patients, surgeons, and healthcare providers.

Innovative Midfoot Solutions (IMS) is developing a new generation of patented surgical technologies designed to change that.

With a global market opportunity the company estimates at more than $1 billion, IMS is targeting two major conditions: midfoot osteoarthritis and progressive collapsing foot deformity (flatfoot).

Its breakthrough approach combines purpose-built implants, minimally invasive surgical techniques, and streamlined instrumentation to potentially improve surgical outcomes while reducing procedural complexity and costs.

Two proprietary platforms are driving the company’s development:
  • OrthoFuse™: An innovative fusion system designed to promote bone healing and simplify surgery for patients with debilitating midfoot arthritis.
  • Precise™ Wedge: An expandable implant system designed to enable more precise, patient-specific correction of foot deformities without the need for multiple implant sizes.

Founded by experienced orthopedic surgeons and medical device executives whose collective track record includes more than 200 commercialized devices, IMS is advancing its technology through an established FDA 510(k) regulatory pathway.

Register for our Executive Briefing to explore the scale of this underserved orthopedic market, the technology behind IMS’s differentiated approach, and the company’s plans to bring its next-generation surgical platforms to market.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.